Carbon Reduction Plan
Arcadia Pharma Ltd – Carbon Reduction Plan Summary
Last Updated: June 2025
Arcadia Pharma Ltd (APL) is committed to achieving Net Zero greenhouse gas (GHG) emissions by 2040, ahead of the UK Government's 2050 target. This Carbon Reduction Plan outlines our progress, current footprint, and future strategy, aligning with PPN 06/21, NHS procurement standards, and the Greening Government Commitments.
Baseline Emissions (2023)
|
Emission Scope |
Source |
Emissions (tCO₂e) |
|
Scope 1 |
Fuel use by business vehicles (personal mileage) |
1.10 |
|
Scope 2 |
Electricity use at our Swansea office |
0.827 |
|
Scope 3 |
Not yet recorded (imports, commuting, waste) |
To be captured |
Most Recent Emissions (2024)
|
Emission Scope |
Emissions (tCO₂e) |
Notes |
|
Scope 1 |
0.55 |
50% reduction via EV transition |
|
Scope 2 |
1.075 |
Increase due to EV charging (green tariff from 2025) |
|
Scope 3 |
In development |
Scope 3 tracking framework launches in 2025 |
Carbon Reduction Measures
- Full transition to electric vehicles (EVs) for staff business mileage.
- Office lighting upgrades to energy-efficient fixtures (ongoing).
- Solar panel installation approved for 2025.
- Implementation of the green electricity tariff in 2025.
- Monthly emissions monitoring (fuel and electricity).
- Company-wide Scope 3 data capture system launching in 2025, covering:
- Business travel
- Employee commuting
- Waste
- Upstream transport from suppliers
Emissions Reduction Targets
|
Year |
Target |
|
2026 |
10% total reduction from 2023 baseline |
|
2028 |
50% reduction |
|
2035 |
78% reduction |
|
2040 |
Net Zero |
Leadership & Accountability
APL’s Executive Board leads this initiative, with quarterly progress reviews and a dedicated Net Zero team. Departmental sustainability champions and an internal carbon dashboard will be introduced in 2025.
Declaration
This plan has been developed in accordance with:
- NHS PPN 06/21 guidance
- Streamlined Energy and Carbon Reporting (SECR) requirements
- Corporate Value Chain (Scope 3) Standard
Signed:
Jason Webb
Director, Arcadia Pharma Ltd
June 2025